ECV-56642-31208
3 vaccinations
6 coded responses
22 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 441 / OH
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-01
Dose 1 — Pfizer-BioNTech
-
2021-02-03
Registered in v-safe
- 2021-02-03
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Fatigue or tirednessFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Fair · Fatigue or tirednessFree text: Decreased appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
-
2021-02-11
Survey response — day 7, dose 1MedDRA: Injection site inflammation — Feeling: GoodFree text: Post inflammatory hyperpigmentation at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-15
-
2021-03-03
Dose 2 — Pfizer-BioNTech
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
- 2021-03-10
- 2021-03-24
- 2021-06-04
-
2021-12-18
Dose 3 — Moderna
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-27
- 2022-01-01
-
2022-01-09
Survey response — day 21, dose 3MedDRA: Fatigue, Nasal congestion — Feeling: GoodFree text: Stuffy nose, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Survey response — day 28, dose 3MedDRA: Fatigue, Nasal congestion, Nasopharyngitis — Feeling: GoodFree text: Cold like symptoms - stuffy nose, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-01-31
- 2022-03-19
-
2022-12-20
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Hyperhidrosis, Myalgia, Pyrexia, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Covid positive - cough, vomiting - 24 times, muscle aches, fatigue, fever, sweatsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2021-12-18 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Bruise at injection site
Systemic reaction (other): Decreased appetite
Release 4 — day 7, dose 1
Systemic reaction (other): Post inflammatory hyperpigmentation at injection site
Release 10 — day 21, dose 3
Symptoms: Stuffy nose, fatigue
Release 10 — day 28, dose 3
Symptoms: Cold like symptoms - stuffy nose, fatigue
Release 12 — 12 months, dose 3
Symptoms: Covid positive - cough, vomiting - 24 times, muscle aches, fatigue, fever, sweats
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site inflammation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release